Clinstile S.A de C.V.
Clinstile S.A de C.V.
Durango 325, Roma Norte, Ciudad de México
Select an option
I am a doctor
I am a sponsor
Our team
Medical staff
RAMIRO GUTIERREZ OCHOA
Julieta Corona
Favio Edmundo Enriquez Sosa
Andrés Blanco Monter
Carlos Pineda Sanchez
Sandra Quiñones
Daniela Cajina-Lopez
Mariana Monter Garrido
Paulina Hernandez
Elena Sazykina
Open studies
Lupus
A Study to Learn About the Safety of Litifilimab (BIIB059) Injections and Whether They Can Improve Symptoms of Adult Participants Who Have Systemic Lupus Erythematosus - TOPAZ-1 - BiogenSee more
A Study to Assess Effectiveness and Safety of Deucravacitinib Compared With Placebo in Participants With Active Systemic Lupus Erythematosus (SLE) - POETYK SLE-1 - Bristol-Myers SquibbSee more
A 2-Part Study to Learn Whether Litifilimab (BIIB059) Injections Can Improve Symptoms of Adult Participants Who Have Active Cutaneous Lupus Erythematosus (AMETHYST) - AMETHYST - BiogenSee more
A Study of Obexelimab in Patients with Systemic Lupus Erythematosus - SunStone - Zenas BioPharma (USA), LLCSee more
Arthritis
A Study of Baricitinib in Participants From 1 Year to Less Than 18 Years Old With Juvenile Idiopathic Arthritis - JUVE-X - Eli Lilly and CompanySee more
A Study of Baricitinib (LY3009104) in Participants From 1 Year to Less Than 18 Years Old With Systemic Juvenile Idiopathic Arthritis (sJIA) - I4V-MC-JAHU - Eli Lilly and CompanySee more
Rare diseases
A Study to Evaluate the Efficacy and Safety of Dazodalibep in Participants With Sjögren's Syndrome (SS) With Moderate-to-severe Systemic Disease Activity - Oasiz - Horizon Therapeutics Ireland DACSee more
A Safety and Efficacy Study of Dazodalibep in Participants With Sjögren's Syndrome (SS) With Moderate-to-Severe Symptom State - AmgenSee more
Migraine
Randomized Study in Children and Adolescents With Migraine: Acute Treatment - Biohaven Pharmaceuticals, Inc.See more
Multiple sclerosis
A Study of Ocrelizumab in Children and Adolescents With Relapsing-Remitting Multiple Sclerosis - Hoffmann-La RocheSee more
